Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 243

Results For "CRO"

4407 News Found

Kokilaben Hospital launches dedicated Hereditary Cancer Clinic
Healthcare | May 01, 2023

Kokilaben Hospital launches dedicated Hereditary Cancer Clinic

Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care


Aarti Drugs reports Q4 FY23 PAT at Rs.56.02 Cr
News | April 30, 2023

Aarti Drugs reports Q4 FY23 PAT at Rs.56.02 Cr

Specialty Chemicals grew 38% YoY for FY23


RPG Life Sciences posts Q4 revenue at Rs 118.49 Cr
News | April 29, 2023

RPG Life Sciences posts Q4 revenue at Rs 118.49 Cr

Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23


Laurus Labs Q4 FY23 consolidated PAT drops to to Rs. 102.98 Cr
News | April 28, 2023

Laurus Labs Q4 FY23 consolidated PAT drops to to Rs. 102.98 Cr

Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects


Syngene International posts Q4 FY2023 consolidated profit at Rs. 178.7 Cr
News | April 27, 2023

Syngene International posts Q4 FY2023 consolidated profit at Rs. 178.7 Cr

The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023


Ipca Laboratories gets 3 observations for Piparia, Silvassa unit
Drug Approval | April 27, 2023

Ipca Laboratories gets 3 observations for Piparia, Silvassa unit

The company will submit its comprehensive response on these observations to the US FDA within the stipulated time


Biocon approves NCD issue
News | April 27, 2023

Biocon approves NCD issue

The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%.


Tricog raises US$ 8.5 million in series B2 funding
News | April 25, 2023

Tricog raises US$ 8.5 million in series B2 funding

The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa


Xyall and Indica Labs forge collaboration to transform precision oncology workflows
News | April 25, 2023

Xyall and Indica Labs forge collaboration to transform precision oncology workflows

Bridging the gap between histopathology and molecular pathology